drugset / Trial / NCT06190132

The Effect of Omega-3 Fatty Acids Versus Gabapentin in Uremic Pruritus in Hemodialysis Patients

NCT06190132

Completed 50 enrolled Ain Shams University
RandomizedCrossoverSingle-blindTreatment

Summary

omega-3 fatty acids versus gabapentin in uremic pruritus in hemodialysis patients.

Timeline

Start
2023-04-01
Primary completion
2023-07-15
Completion
2023-07-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 100 mg
Comparator Lovaza Other / unclassified 1 g

Indications

No indication recorded.